{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:09:58Z","timestamp":1792548598018,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["No.CX20240297"],"award-info":[{"award-number":["No.CX20240297"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["CX20240297"],"award-info":[{"award-number":["CX20240297"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2023RC1032"],"award-info":[{"award-number":["2023RC1032"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["40"],"award-info":[{"award-number":["40"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thromres.2025.109294","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T18:04:33Z","timestamp":1740938673000},"page":"109294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"249","author":[{"given":"Kun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-cong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109294_bb0005","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in Cancer patients: a population-based cohort study","volume":"14","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109294_bb0010","first-page":"832","article-title":"The efficacy and safety of low molecular weight heparin administration to improve survival of Cancer patients: a systematic review and Meta-analysis","volume":"05","author":"Montroy","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0015","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with Cancer, including patients with COVID-19","volume":"7","author":"Farge","year":"2022","journal-title":"Lancet Oncol."},{"issue":"Suppl","key":"10.1016\/j.thromres.2025.109294_bb0020","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9Th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"2","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2025.109294_bb0025","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1245\/s10434-018-6671-7","article-title":"Venous thromboembolic events following major pelvic and abdominal surgeries for Cancer: a prospective cohort study","volume":"11","author":"Serrano","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.thromres.2025.109294_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/dmcn.14306","article-title":"Optimal clinical Management of Children Receiving Ketogenic Parenteral Nutrition: a clinical practice guide","volume":"1","author":"van der Louw","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.thromres.2025.109294_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update","volume":"5","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2025.109294_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and Management of Acute Pulmonary Embolism Developed in collaboration with the European Respiratory Society (ERS)","volume":"4","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2025.109294_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","article-title":"Extended Thromboprophylaxis following major abdominal\/pelvic Cancer-related surgery: a systematic review and Meta-analysis of the literature","author":"Knoll","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109294_bb0050","first-page":"832","article-title":"The efficacy and safety of low molecular weight heparin administration to improve survival of Cancer patients: a systematic review and Meta-analysis","volume":"5","author":"Montroy","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0055","article-title":"Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin","volume":"9","author":"Saheb","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2025.109294_bb0060","article-title":"Production and chemical processing of low molecular weight heparins","volume":"5-16","author":"Linhardt","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0065","article-title":"Comparative pharmacokinetics of LMWHs","volume":"31-38","author":"Samama","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"issue":"264\u2013269","key":"10.1016\/j.thromres.2025.109294_bb0070","first-page":"W64","article-title":"Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement","volume":"4","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109294_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of Antihemostatic medicinal products in non-surgical patients","volume":"4","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0080","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"11","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.775126","article-title":"New Oral anticoagulants for venous thromboembolism prophylaxis in Total hip and knee arthroplasty: a systematic review and network Meta-analysis","volume":"12","author":"Yi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.thromres.2025.109294_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in Meta-analyses","volume":"7414","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2025.109294_bb0095","article-title":"Increased risk of myocardial infarction with dabigatran Etexilate: fact or fiction? A critical Meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies","volume":"1-7","author":"Wei","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2025.109294_bb0100","first-page":"5","article-title":"Comparative effectiveness of interventions for stroke prevention in atrial fibrillation: a network Meta-analysis","author":"Tereshchenko","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2025.109294_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.1988.tb01268.x","article-title":"Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin\u00ae) in the prophylaxis of thromboembolic complications of abdominal oncological surgery","volume":"6","author":"Fricker","year":"1988","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.thromres.2025.109294_bb0110","first-page":"166","article-title":"Prevention of postoperative deep vein thrombosis in Cancer patients. A randomized trial with low molecular weight heparin (CY 216)","volume":"2","author":"Marassi","year":"1993","journal-title":"Int. Surg."},{"key":"10.1016\/j.thromres.2025.109294_bb0115","first-page":"1099","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective Cancer surgery: a double-blind randomized multicentre trial with Renographic assessment","volume":"8","author":"Berqvist","year":"1997","journal-title":"Brit. J. Surg."},{"key":"10.1016\/j.thromres.2025.109294_bb0120","first-page":"815","article-title":"Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on Cancer survival following breast and pelvic Cancer surgery: a prospective randomized double-blind trial","volume":"4","author":"von Tempelhoff","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.thromres.2025.109294_bb0125","first-page":"989","article-title":"Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial","volume":"6","author":"Maxwell","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2025.109294_bb0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for Cancer","volume":"13","author":"Bergqvist","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109294_bb0135","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1538-7836.2006.02083.x","article-title":"A randomized study comparing the efficacy and safety of Nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for Cancer","volume":"8","author":"Simonneau","year":"2006","journal-title":"J. Thromb. Haemos."},{"key":"10.1016\/j.thromres.2025.109294_bb0140","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.thromres.2009.09.009","article-title":"Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic Cancer surgery: results from a multicenter, randomized","volume":"3","author":"Sakon","year":"2010","journal-title":"Open-Label Study. Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109294_bb0145","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with Bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for Cancer: the CANBESURE randomized study","volume":"6","author":"Kakkar","year":"2010","journal-title":"J. Thromb. Haemos."},{"key":"10.1016\/j.thromres.2025.109294_bb0150","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jog.12740","article-title":"Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy","volume":"9","author":"Nagata","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.thromres.2025.109294_bb0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/iju.13189","article-title":"Safety of Fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial","volume":"11","author":"Hata","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.thromres.2025.109294_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamasurg.2018.2081","article-title":"Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma: the PROTECTOR randomized clinical trial","volume":"10","author":"Jung","year":"2018","journal-title":"JAMA Surg."},{"key":"10.1016\/j.thromres.2025.109294_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00595-019-01859-w","article-title":"Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal Cancer surgery: a randomized-controlled trial (YCOG 1404)","volume":"1","author":"Nakagawa","year":"2020","journal-title":"Surg. Today"},{"key":"10.1016\/j.thromres.2025.109294_bb0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jamcollsurg.2020.08.734","article-title":"Efficacy and safety of low-molecular-weight heparin on prevention of venous thromboembolism after laparoscopic operation for gastrointestinal malignancy in Japanese patients: a multicenter, open-label, prospective, randomized controlled trial","volume":"5","author":"Obitsu","year":"2020","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.thromres.2025.109294_bb0175","article-title":"Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery","volume":"25","author":"Yu","year":"2020","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.thromres.2025.109294_bb0180","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/bjs5.50323","article-title":"Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial","volume":"4","author":"Kamachi","year":"2020","journal-title":"BJS Open"},{"key":"10.1016\/j.thromres.2025.109294_bb0185","first-page":"6","article-title":"Safety and efficacy of Apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.thromres.2025.109294_bb0190","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.35755\/jmedassocthai.2021.S05.00061","article-title":"Outcomes comparison between low molecular-weight heparin with mechanical prophylaxis versus mechanical prophylaxis alone for perioperative venous thromboembolism prevention in abdominopelvic surgery: a randomized controlled trial","volume":"104","author":"Kittitirapong","year":"2021","journal-title":"J. Med. Assoc. Thail."},{"key":"10.1016\/j.thromres.2025.109294_bb0195","article-title":"Rivaroxaban versus enoxaparin for Thromboprophylaxis after major gynecological Cancer surgery: the VALERIA trial: venous thromboembolism prophylAxis after gynecoLogical pElvic Cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)","volume":"1309653236","author":"Longo","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1877-1173(10)93020-2","article-title":"Glycosaminoglycans and activated contact system in Cancer patient plasmas","author":"Pan","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.thromres.2025.109294_bb0205","first-page":"648","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk Cancer patients undergoing chemotherapy in the United States","volume":"3","author":"Khorana","year":"2013","journal-title":"Cancer-Am. Cancer Soc."},{"key":"10.1016\/j.thromres.2025.109294_bb0210","first-page":"10","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","author":"Abdol","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.thromres.2025.109294_bb0215","first-page":"832","article-title":"The efficacy and safety of low molecular weight heparin administration to improve survival of Cancer patients: a systematic review and Meta-analysis","volume":"5","author":"Montroy","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0220","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1245\/s10434-008-0151-4","article-title":"Venous thromboembolism in Cancer patients undergoing major surgery","volume":"12","author":"Osborne","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.thromres.2025.109294_bb0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.medcli.2022.06.022","article-title":"Efficacy and safety of direct Oral anticoagulants for the treatment of Cancer-associated venous thromboembolism: a systematic review and Bayesian network Meta-analysis","volume":"6","author":"Ning","year":"2023","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.thromres.2025.109294_bb0230","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00464-023-10649-y","article-title":"Direct Oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended Thromboprophylaxis following major abdominal\/pelvic Cancer-related surgery: a systematic review and Meta-analysis","volume":"3","author":"Zhou","year":"2024","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.thromres.2025.109294_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.pmbts.2019.02.003","article-title":"Low molecular weight heparins and their clinical applications","author":"Hao","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.thromres.2025.109294_bb0240","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0735-1097(02)02901-7","article-title":"The role of low-molecular-weight heparin in the Management of Acute Coronary Syndromes","volume":"4 Suppl S","author":"Cohen","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109294_bb0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000521698","article-title":"Anticoagulation practice in patients with Cancer-associated thrombosis: insights from GeCAT, a German prospective registry study","volume":"4","author":"Klamroth","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.thromres.2025.109294_bb0250","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"10","author":"Klerk","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2025.109294_bb0255","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1538-7836.2006.02083.x","article-title":"A randomized study comparing the efficacy and safety of Nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for Cancer","volume":"8","author":"Simonneau","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0260","first-page":"D6649","article-title":"Anticoagulation for the initial treatment of venous thromboembolism in people with Cancer","volume":"12","author":"Kahale","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.thromres.2025.109294_bb0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MBC.0000000000001281","article-title":"Real-world comparative effectiveness of Dalteparin and enoxaparin for venous thromboembolism prophylaxis","volume":"3","author":"Di Mauro","year":"2024","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2025.109294_bb0270","first-page":"73","article-title":"The use of Parnaparin sodium (Fluxum) in the prevention of thromboembolic complications after surgical treatment of fractures associated with high risks of thrombosis","volume":"10","author":"Kaplunov","year":"2020","journal-title":"Khirurgiia (Mosk)"},{"key":"10.1016\/j.thromres.2025.109294_bb0275","article-title":"Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery","volume":"25","author":"Yu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2025.109294_bb0280","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/aor.12475","article-title":"Pharmacokinetics of Certoparin during in vitro and in vivo Dialysis","volume":"11","author":"Krieter","year":"2015","journal-title":"Artif. Organs"},{"key":"10.1016\/j.thromres.2025.109294_bb0285","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029611433769","article-title":"Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast Cancer or stage III\/IV lung Cancer","volume":"2","author":"Haas","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109294_bb0290","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/erc.10.35","article-title":"New challenges for a second-generation low-molecular-weight heparin: focus on Bemiparin","volume":"5","author":"Martinez-Gonzalez","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.thromres.2025.109294_bb0295","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1076029617753538","article-title":"Effectiveness and safety of LMWH treatment in patients with Cancer diagnosed with non-high-risk venous thromboembolism: Turkish observational study (TREBECA)","volume":"6","author":"Ozaslan","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482500043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:20:37Z","timestamp":1778664037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482500043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":59,"alternative-id":["S004938482500043X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109294","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109294"}}